Protein Quality Control in Alzheimer's Disease: A Fatal Saviour

E-ISSN： 2212-5299|4|3|283-292

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.4, Iss.3, 2005-06, pp. : 283-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Endoplasmic Reticulum Protein Quality Control in Neurodegenerative Disease: The Good, the Bad and the Therapy

Current Medicinal Chemistry, Vol. 16, Iss. 5, 2009-02 ,pp. : 615-626

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Tau Protein in Alzheimer's Disease

By Gong Cheng-Xin Grundke-Iqbal Inge Iqbal Khalid

Drugs & Aging, Vol. 27, Iss. 5, 2010-05 ,pp. : 351-365

Adis International

Access to resources Recommend Favorite

Metal-protein attenuating compounds and Alzheimer’s disease

By Ritchie Craig W Bush Ashley I Masters Colin L

Expert Opinion on Investigational Drugs, Vol. 13, Iss. 12, 2004-12 ,pp. : 1585-1592

Informa Healthcare

Access to resources Recommend Favorite

Cholinergic Activity and Amyloid Precursor Protein Processing in Aging and Alzheimer's Disease

Current Drug Targets-CNS & Neurological Disorders, Vol. 3, Iss. 2, 2004-04 ,pp. : 137-152

Bentham Science Publishers

Access to resources Recommend Favorite

Metal-Protein Attenuating Compounds (MPACs) for the Treatment of Alzheimer's Disease

Drug Design Reviews - Online, Vol. 1, Iss. 1, 2004-01 ,pp. : 75-82

Bentham Science Publishers

Access to resources Recommend Favorite